mTORC1与肺动脉高压。处于血管收缩和血管重塑的十字路口？ - Suppr

Suppr

超能文献

mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?

作者信息

Goncharova Elena A, Simon Marc A, Yuan Jason X-J

机构信息

Pittsburgh Heart, Lung, and Blood Vascular Medicine InstituteUniversity of PittsburghPittsburgh, Pennsylvaniaand.

Division of Pulmonary, Critical Care, and Sleep MedicineUniversity of California, San DiegoLa Jolla, California.

出版信息

Am J Respir Crit Care Med. 2020 May 15;201(10):1177-1179. doi: 10.1164/rccm.202001-0087ED.

DOI:10.1164/rccm.202001-0087ED

PMID:31968178

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7233339/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ff/7233339/3621ce8b3445/rccm.202001-0087ED_f1.jpg

相似文献

mTORC1 in Pulmonary Arterial Hypertension. At the Crossroads between Vasoconstriction and Vascular Remodeling?

Am J Respir Crit Care Med. 2020 May 15;201(10):1177-1179. doi: 10.1164/rccm.202001-0087ED.

Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.

Am J Respir Crit Care Med. 2020 May 15;201(10):1263-1276. doi: 10.1164/rccm.201911-2137OC.

Loss of prolyl hydroxylase 1 and 2 in SM22α-expressing cells prevents Hypoxia-Induced pulmonary hypertension.

Am J Physiol Lung Cell Mol Physiol. 2023 Dec 1;325(6):L741-L755. doi: 10.1152/ajplung.00428.2022. Epub 2023 Oct 17.

Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension.

Respir Res. 2023 Nov 1;24(1):263. doi: 10.1186/s12931-023-02559-3.

Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.

Circ Res. 2022 Mar 4;130(5):760-778. doi: 10.1161/CIRCRESAHA.121.319100. Epub 2022 Feb 7.

Blood Flow Disturbances in Congenital Heart Disease: Is Neuroblastoma Suppressor of Tumorigenicity 1 a Target for Preventing Pulmonary Vascular Remodeling?

Am J Respir Cell Mol Biol. 2022 Dec;67(6):615-616. doi: 10.1165/rcmb.2022-0368ED.

Hiding in Plain Sight: The Basement Membrane in Pulmonary Vascular Remodeling.

Am J Respir Cell Mol Biol. 2020 Jul;63(1):13-14. doi: 10.1165/rcmb.2020-0100ED.

In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension.

Am J Respir Crit Care Med. 2021 Mar 1;203(5):541-542. doi: 10.1164/rccm.202009-3706ED.

Immune Cells in Pulmonary Arterial Hypertension.

Heart Lung Circ. 2022 Jul;31(7):934-943. doi: 10.1016/j.hlc.2022.02.007. Epub 2022 Mar 28.

Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension.

Int J Mol Sci. 2023 Feb 19;24(4):4147. doi: 10.3390/ijms24044147.

引用本文的文献

Class III Phosphatidylinositol-3 Kinase/Vacuolar Protein Sorting 34 in Cardiovascular Health and Disease.

J Cardiovasc Transl Res. 2025 Apr;18(2):392-407. doi: 10.1007/s12265-024-10581-z. Epub 2025 Jan 16.

Hypoxia-induced TPC2 transcription and glycosylation aggravates pulmonary arterial hypertension by blocking autophagy flux.

Sci Rep. 2024 Dec 28;14(1):31223. doi: 10.1038/s41598-024-82552-y.

New trends in pulmonary hypertension.

Eur Respir Rev. 2023 Feb 21;32(167). doi: 10.1183/16000617.0211-2022. Print 2023 Mar 31.

Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca signaling.

Physiol Rev. 2023 Jul 1;103(3):1827-1897. doi: 10.1152/physrev.00030.2021. Epub 2022 Nov 24.

Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.

Am J Physiol Lung Cell Mol Physiol. 2022 May 1;322(5):L737-L760. doi: 10.1152/ajplung.00447.2021. Epub 2022 Mar 23.

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension.

Front Pharmacol. 2021 Nov 11;12:758763. doi: 10.3389/fphar.2021.758763. eCollection 2021.

TRPC6, a therapeutic target for pulmonary hypertension.

Am J Physiol Lung Cell Mol Physiol. 2021 Dec 1;321(6):L1161-L1182. doi: 10.1152/ajplung.00159.2021. Epub 2021 Oct 27.

Endothelial upregulation of mechanosensitive channel Piezo1 in pulmonary hypertension.

Am J Physiol Cell Physiol. 2021 Dec 1;321(6):C1010-C1027. doi: 10.1152/ajpcell.00147.2021. Epub 2021 Oct 20.

Upregulation of Calcium Homeostasis Modulators in Contractile-To-Proliferative Phenotypical Transition of Pulmonary Arterial Smooth Muscle Cells.

Front Physiol. 2021 Aug 2;12:714785. doi: 10.3389/fphys.2021.714785. eCollection 2021.

Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension.

Pulm Circ. 2020 Sep 10;10(3):2045894020948470. doi: 10.1177/2045894020948470. eCollection 2020 Jul-Sep.

本文引用的文献

Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.

Am J Respir Crit Care Med. 2020 May 15;201(10):1263-1276. doi: 10.1164/rccm.201911-2137OC.

Smooth Muscle Cell Phenotypic Diversity.

Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1715-1723. doi: 10.1161/ATVBAHA.119.312131. Epub 2019 Jul 25.

Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension.

JACC Basic Transl Sci. 2018 Dec 31;3(6):744-762. doi: 10.1016/j.jacbts.2018.08.009. eCollection 2018 Dec.

The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.

Front Cardiovasc Med. 2018 Dec 17;5:179. doi: 10.3389/fcvm.2018.00179. eCollection 2018.

Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells.

PLoS One. 2018 Nov 1;13(11):e0205195. doi: 10.1371/journal.pone.0205195. eCollection 2018.

Prostanoid EP₂ Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells.

Int J Mol Sci. 2018 Aug 12;19(8):2372. doi: 10.3390/ijms19082372.

Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.

Am J Respir Cell Mol Biol. 2017 Nov;57(5):615-625. doi: 10.1165/rcmb.2016-0364OC.

Virus-induced inflammasome activation is suppressed by prostaglandin D/DP1 signaling.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):E5444-E5453. doi: 10.1073/pnas.1704099114. Epub 2017 Jun 19.

mTOR Signaling in Growth, Metabolism, and Disease.

Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.

Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.

Am J Respir Crit Care Med. 2017 Feb 15;195(4):425-437. doi: 10.1164/rccm.201606-1226PP.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验